Kevin Mcloughlin's Contact Details

Kevin Mcloughlin's Company Details

ATOM | Accelerating Therapeutics for Opportunities in Medicine

San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium is a public-private partnership with the mission accelerating the development of more effective therapies for patients. Our goal is to transform drug discovery from a slow, sequential, and high-failure process into a rapid, integrated, and patient-centric model. We are integrating high performance computing, diverse biological data, and emerging biotechnologies to create a new pre-competitive platform for drug discovery.